These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9443541)

  • 1. Action of the 5-HT2A antagonist amperozide on alcohol-induced poikilothermia in rats.
    Myers RD; Lankford M
    Pharmacol Biochem Behav; 1998 Jan; 59(1):91-5. PubMed ID: 9443541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974.
    Overstreet DH; McArthur RA; Rezvani AH; Post C
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1448-54. PubMed ID: 9394117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats.
    Myers RD; Lankford MF; Björk A
    Pharmacol Biochem Behav; 1993 Jul; 45(3):741-7. PubMed ID: 8332634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide.
    Myers RD; Lankford M; Björk A
    Pharmacol Biochem Behav; 1992 Nov; 43(3):661-7. PubMed ID: 1448464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol's effect on body temperature: hypothermia, hyperthermia or poikilothermia?
    Myers RD
    Brain Res Bull; 1981 Aug; 7(2):209-20. PubMed ID: 6974036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate and 5-HT2A receptors in alcohol drinking: preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide.
    Lankford MF; Myers RD
    Alcohol; 1996; 13(1):53-7. PubMed ID: 8837935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats.
    Lankford MF; Björk AK; Myers RD
    Alcohol; 1996; 13(4):399-404. PubMed ID: 8836330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of dopamine and 5-HT in anatomical regions of the rat's brain is unaffected by sustained infusion of amperozide.
    Adell A; Myers RD
    Pharmacol Toxicol; 1995 Nov; 77(5):341-5. PubMed ID: 8778747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the action of the 5-HT2 antagonists amperozide and trazodone on preference for alcohol in rats.
    McMillen BA; Walter S; Williams HL; Myers RD
    Alcohol; 1994; 11(3):203-6. PubMed ID: 8060520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide.
    Myers RD; Lankford M; Björk A
    Alcohol; 1993; 10(2):117-25. PubMed ID: 8442888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats.
    Biggs TA; Myers RD
    Pharmacol Biochem Behav; 1998 Jun; 60(2):407-13. PubMed ID: 9632223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amperozide influences feeding independently of 5-HT2A receptor antagonism.
    Price IV; Gorzalka BB; White SJ; Arkinstall KH
    Neuropsychobiology; 1998; 37(3):155-9. PubMed ID: 9597673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is alcohol induced poikilothermia mediated by 5-HT and catecholamine receptors or by ionic set-point mechanism in the brain?
    Myers RD; Ruwe WD
    Pharmacol Biochem Behav; 1982 Feb; 16(2):321-7. PubMed ID: 7071083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.
    McMillen BA; Jones EA; Hill LJ; Williams HL; Björk A; Myers RD
    Pharmacol Biochem Behav; 1993 Sep; 46(1):125-9. PubMed ID: 8255902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiovascular effects of amperozide: interactions with cocaine.
    Jones EA; McMillen BA
    Pharmacol Toxicol; 1999 Feb; 84(2):53-8. PubMed ID: 10068147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol drinking in rats is attenuated by the mixed 5-HT1 agonist/5-HT2 antagonist FG 5893.
    Singh GK; Kalmus GW; Björk AK; Myers RD
    Alcohol; 1993; 10(3):243-8. PubMed ID: 8507395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.
    Piercy KT; Björk AK; Myers RD
    Alcohol; 1996; 13(5):521-7. PubMed ID: 8888950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist.
    Axelsson R; Nilsson A; Christensson E; Björk A
    Psychopharmacology (Berl); 1991; 104(3):287-92. PubMed ID: 1924636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.